Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives.

Crizotinib is a first-in-class oral anaplastic lymphoma kinase (ALK) inhibitor targeting ALK-rearranged non-small-cell lung cancer. The therapy was approved by the US FDA in August 2011 and received conditional marketing approval by the European Commission in October 2012 for advanced non-small-cell lung cancer. A break-apart FISH-based assay was jointly approved with crizotinib by the FDA. This assay and an immunohistochemistry assay that uses a D5F3 rabbit monoclonal primary antibody were also approved for marketing in Europe in October 2012. While ALK rearrangement has relatively low prevalence, a clinical benefit is exhibited in more than 85% of patients with median progression-free survival of 8-10 months. In this article, the authors summarize the therapy and alternative test strategies for identifying patients who are likely to respond to therapy, including key issues for effective and efficient testing. The key economic considerations regarding the joint companion diagnostic and therapy are also presented. Given the observed clinical benefit and relatively high cost of crizotinib therapy, companion diagnostics should be evaluated relative to response to therapy versus correlation alone whenever possible, and both high inter-rater reliability and external quality assessment programs are warranted.

Projecte web "Viatges a Patrimonis de la Humanitat" (Ass. Amics Unesco Barcelona)

Treball Final Carrera sobre la gestió d'un projecte web, de gestió de continguts multimèdia, de creació i coordinació d'un equip de voluntaris per a la divulgació en línia i el foment dels viatges culturals als llocs Patrimoni de la Humanitat realitzats per una entitat intercultural catalana, Amics de la UNESCO de Barcelona.

SwissDock, a protein-small molecule docking web service based on EADock DSS.

Most life science processes involve, at the atomic scale, recognition between two molecules. The prediction of such interactions at the molecular level, by so-called docking software, is a non-trivial task. Docking programs have a wide range of applications ranging from protein engineering to drug design. This article presents SwissDock, a web server dedicated to the docking of small molecules on target proteins. It is based on the EADock DSS engine, combined with setup scripts for curating common problems and for preparing both the target protein and the ligand input files. An efficient Ajax/HTML interface was designed and implemented so that scientists can easily submit dockings and retrieve the predicted complexes. For automated docking tasks, a programmatic SOAP interface has been set up and template programs can be downloaded in Perl, Python and PHP. The web site also provides an access to a database of manually curated complexes, based on the Ligand Protein Database. A wiki and a forum are available to the community to promote interactions between users. The SwissDock web site is available online at http://www.swissdock.ch. We believe it constitutes a step toward generalizing the use of docking tools beyond the traditional molecular modeling community.

Anàlisi i proposta de renovació de la web dels Estudis d'Humanitats i Filologia de la UOC

Aquest treball té com a finalitat, d'una banda, col·laborar a determinar les mancances, tant de disseny com de contingut, que té actualment el web dels Estudis d'Humanitats i Filologia de la UOC i, de l'altra, fer una proposta d'un nou disseny, que inclogui la reestructuració dels continguts.

Experimentació amb eina d'àudio i vídeo a la carta i arxiu multidocumental en entorn web

L'objectiu d'aquest pràcticum és treballar amb una eina d'edició i catalogació remota de vídeos accessible via internet. L'eina ha estat desenvolupada per l'empresa Vision Robotics. La memòria reflecteix les experiències viscudes a través del treball amb aquesta eina i analitza les possibilitats de millora, les potencialitats de l'eina a més d'afegir unes reflexions finals de l'eina en general.

Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing.

AIM: Antidoping procedures are expected to greatly benefit from untargeted metabolomic approaches through the discovery of new biomarkers of prohibited substances abuse. RESULTS: Endogenous steroid metabolites were monitored in urine samples from a controlled elimination study of testosterone undecanoate after ingestion. A platform coupling ultra-high pressure LC with high-resolution quadrupole TOF MS was used and high between-subject metabolic variability was successfully handled using a multiblock data analysis strategy. Links between specific subsets of metabolites and influential genetic polymorphisms of the UGT2B17 enzyme were highlighted. CONCLUSION: This exploratory metabolomic strategy constitutes a first step toward a better understanding of the underlying patterns driving the high interindividual variability of steroid metabolism. Promising biomarkers were selected for further targeted study.

TFC - IHO : usabilitat web venda de parquets de bambú

Des de fa ja alguns anys que el sector de la construcció està malmès degut a la crisi econòmica actual i moltes de les empreses que hi ha no aconsegueixen sortir del pou i tenen seriosos problemes per a vendre els seus productes o serveis. És aquí on sorgeix una magnífica possibilitat d'utilitzar tècniques d'usabilitat i accessibilitat Web que poden permetre a les empreses del sector de la construcció millorar els ratis tant de captació com de fidelització de clients ja que la idea és aconseguir realitzar una Web pensada en l'usuari i per l'usuari tenint en compte sempre les seves necessitats. Com el sector és molt estès i per ser competitiu cal tenir algun factor diferenciador, com per exemple el de la sostenibilitat que està tan de moda, en aquest projecte s'ha volgut treballar amb una empresa que acompleix tots dos requisits: ven parquet de bambú i alhora aquesta planta és totalment sostenible.

TFC - Accesibilidad web

Estudio de 10 webs del portal uoc.edu, basado en las pautas de accesibilidad web W3C

DCU per a la configurabilitat d'una estació de treball clínic

Gairebé un 50% dels metges de la sanitat catalana realitzen actualment les seves tasques assistencials en entorns SAP. Donada la naturalesa de la seva feina, és fàcil afirmar que les aplicacions que utilitzen habitualment haurien d'haver estat desenvolupades centrant l'atenció en l'usuari i el context en què aquest realitza la seva feina. Però degut a diversos motius organitzatius, això no ha estat així. Aquest projecte pretén demostrar el valor afegit que pot aportar el Disseny Centrat en l'Usuari en el desenvolupament d'aplicacions assistencials en l'àmbit SAP Sanitat. S'ha realitzat una investigació prèvia de les necessitats reals dels usuaris, un anàlisi del context d'ús i dels diferents perfils de usuari, s'ha desenvolupat un prototip amb la nova tecnologia que aporta SAP per al desenvolupament de interfícies tipus web integrades en el sistema (SAP Webdynpro for ABAP), i finalment s'ha realitzat la corresponent avaluació heurística i el test de usuaris. S'ha arribat principalment a tres conclusions: en primer lloc, ha sorprès la bona disposició dels usuaris metges per a participar en aquesta mena de projectes; en segon lloc, ha quedat demostrada la importància de l'anàlisi del context, així com la rellevància que el dissenyador estigui quan més a prop millor de l'usuari final; i finalment, cal destacar que la tecnologia emprada ha limitat qualitativament diverses opcions de disseny.

Sequence-Based Hepatitis B Virus Antiviral Resistance Testing in Switzerland

BACKGROUND: A growing number of patients with chronic hepatitis B is being treated for extended periods with nucleoside and/or nucleotide analogs. In this context, antiviral resistance represents an increasingly common and complex issue. METHODS: Mutations in the hepatitis B virus (HBV) reverse transcriptase (rt) gene and viral genotypes were determined by direct sequencing of PCR products and alignment with reference sequences deposited in GenBank. RESULTS: Plasma samples from 60 patients with chronic hepatitis B were analyzed since March 2009. The predominant mutation pattern identified in patients with virological breakthrough was rtM204V/I ± different compensatory mutations, conferring resistance to L-nucleosides (lamivudine, telbivudine, emtricitabine) and predisposing to entecavir resistance (n = 18). Complex mutation patterns with a potential for multidrug resistance were identified in 2 patients. Selection of a fully entecavir resistant strain was observed in a patient exposed to lamivudine alone. Novel mutations were identified in 1 patient. Wild-type HBV was identified in 9 patients with suspected virological breakthrough, raising concerns about treatment adherence. No preexisting resistance mutations were identified in treatment-naïve patients (n = 13). Viral genome amplification and sequencing failed in 16 patients, of which only 2 had a documented HBV DNA > 1000 IU/ml. HBV genotypes were D in 28, A in 6, B in 4, C in 3 and E in 3 patients. Results will be updated in August 2010 and therapeutic implications discussed. CONCLUSIONS: With expanding treatment options and a growing number of patients exposed to nucleoside and/or nucleotide analogs, sequence-based HBV antiviral resistance testing is expected to become a cornerstone in the management of chronic hepatitis B.

Estudio de la accesibilidad web en la Universitat Oberta de Catalunya

En la relación de la UOC con sus alumnos a través de un medio electrónico, hay que tener en cuenta algunas variables que pueden llegar a ser, y de hecho son, una barrera infranqueable en el acceso al contenido de los sitios web. Este trabajo describe estas barreras y los medios para evitarlas a través de un análisis del diseño del site UOC teniendo en cuenta en todo momento las normas WCAG 1.0 y WCAG 2.0.

Evaluation of indirect susceptibility testing of Mycobacterium tuberculosis to the first- and second-line, and alternative drugs by the newer MB/BacT system

In order to evaluate the Organon Teknika MB/BacT system used for testing indirect susceptibility to the alternative drugs ofloxacin (OFLO), amikacin (AMI), and rifabutin (RIF), and to the usual drugs of standard treatment regimes such as rifampin (RMP), isoniazid (INH), pyrazinamide (PZA), streptomycin (SM), ethambutol (EMB), and ethionamide (ETH), cultures of clinical specimens from 117 patients with pulmonary tuberculosis under multidrug-resistant investigation, admitted sequentially for examination from 2001 to 2002, were studied. Fifty of the Mycobacterium tuberculosis cultures were inoculated into the gold-standard BACTEC 460 TB (Becton Dickinson) for studying resistance to AMI, RIF, and OFLO, and the remaining 67 were inoculated into Lowenstein Jensen (LJ) medium (the gold standard currently used in Brazil) for studying resistance to RMP, INH, PZA, SM, EMB, and ETH. We observed 100% sensitivity for AMI (80.8-100), RIF (80.8-100), and OFLO (78.1-100); and 100% specificity for AMI (85.4-100), RIF (85.4-100), and OFLO (86.7-100) compared to the BACTEC system. Comparing the results obtained in LJ we observed 100% sensitivity for RMP (80-100), followed by INH - 95% (81.8-99.1), EMB - 94.7% (71.9-99.7), and 100% specificity for all drugs tested except for PZA - 98.3 (89.5-99.9) at 95% confidence interval. The results showed a high level of accuracy and demonstrated that the fully automated, non-radiometric MB/BacT system is indicated for routine use in susceptibility testing in public health laboratories.

Trabajo final de carrera : accesibilidad web

Evaluación manual de 10 páginas web siguiendo la pautas WCAG 1.0 y WCAG 2.0.